MedPath

Treating breathing difficulties in young children diagnosed with bronchiolitis

Not Applicable
Completed
Conditions
Specialty: Children, Primary sub-specialty: Respiratory and Cystic Fibrosis
UKCRC code/ Disease: Infection/ Other viral diseases, Respiratory/ Other acute lower respiratory infections
Respiratory
Infection/ Other viral diseases, Respiratory
Registration Number
ISRCTN75766048
Lead Sponsor
Alder Hey Children's NHS Foundation Trust
Brief Summary

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30428935 protocol 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35264343/ Core outcome set development results (added 11/03/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
115
Inclusion Criteria

1. Parents/carers of a hospitalised child (including emergency department (ED) attenders), aged 0-24 months, with a clinical diagnosis of bronchiolitis defined as per NICE Bronchiolitis Guidelines (2015): Diagnose bronchiolitis if the child has a coryzal prodrome lasting 1 to 3 days, followed by: persistent cough and either tachypnoea or chest recession (or both) and either wheeze or crackles on chest auscultation (or both)
2. HCPs who have at least six months experience in managing children diagnosed with bronchiolitis in the following clinical locations: ED, acute assessment unit, medical wards and critical care unit

Exclusion Criteria

Parents/legal representatives who are unable to consent or unable to participate in the workshops or interviews in English. Due to the amount of planned topics to cover it would be impractical to conduct the workshop or interviews using an interpreter.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
At the end of the NOVEMBR feasibility study, the trialists aim to be in a position to decide whether to proceed with a future definitive trial comparing different methods of non-invasive ventilation for managing children with bronchiolitis. If this is the case, a provisional study design and protocol will be written which is acceptable to important stakeholders. A bronchiolitis core outcome set will have been developed to improve standardisation, measurement and reporting of outcomes.This is done through stakeholder workshops, interviews and Delphi surveys.
Secondary Outcome Measures
NameTimeMethod
There are no secondary outcome measures
© Copyright 2025. All Rights Reserved by MedPath